Start for free
Start for free
Mitsui Global Investment logo

Mitsui Global Investment

North America, California, United States, Menlo Park

Description

Mitsui Global Investmen is a venture capital fund that focuses on early stage companies. Mitsui's expertise lies in helping

Investor Profile

Mitsui Global Investment has made 146 investments, with 1 in the past 12 months and 14% as lead.

Stage Focus

  • Series C (26%)
  • Series B (25%)
  • Series A (16%)
  • Series Unknown (14%)
  • Series D (11%)
  • Series E (3%)
  • Post Ipo Equity (1%)
  • Seed (1%)
  • Debt Financing (1%)
  • Private Equity (1%)

Country Focus

  • United States (73%)
  • China (7%)
  • Israel (4%)
  • Canada (3%)
  • United Kingdom (3%)
  • Japan (3%)
  • India (2%)
  • Singapore (1%)
  • Belgium (1%)
  • Indonesia (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Manufacturing
  • Mobile
  • Medical
  • Wireless
  • Security
  • Internet
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mitsui Global Investment frequently co-invest with?

Sequoia Capital
Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 5
Sofinnova Investments
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 5
Canaan Partners
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 5
Kleiner Perkins
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 9
Goldman Sachs
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 8
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 5
General Motors Ventures
General Motors Ventures
North America, Michigan, United States, Warren
Co-Investments: 5
Walden International
Walden International
North America, California, United States, San Francisco
Co-Investments: 5
Samsung Ventures
Samsung Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 6
Intel Capital
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 5

Which angels does Mitsui Global Investment often collaborate with?

CG
Chris Gibson
North America, Utah, United States, Salt Lake City
Shared Deals: 1
BB
Blake Borgeson
North America, Utah, United States, Salt Lake City
Shared Deals: 1
AL
Andrew Leto
North America, Arizona, United States, Phoenix
Shared Deals: 1
PS
Paul Sims
North America, Georgia, United States, Atlanta
Shared Deals: 1
CR
Christian Reitberger
Europe, Bayern, Germany, Munich
Shared Deals: 1
SN
Shane Neman
North America, Florida, United States, Miami
Shared Deals: 1
Boon Hwee Koh
Boon Hwee Koh
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
David Stern
David Stern
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Mitsui Global Investment?

Reunion Neuroscience

Toronto, Ontario, Canada

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

BiotechnologyMental HealthPharmaceutical
Series AMay 2, 2024
Amount Raised: $103,000,000
Leash Biosciences

Salt Lake City, Utah, United States

Leash Biosciences engages in machine learning to solve medicinal chemistry.

Health CareMachine LearningMedical
SeedApr 5, 2024
Amount Raised: $9,300,000
QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series AMay 13, 2020
Amount Raised: $42,000,000
Rallybio

Farmington, Connecticut, United States

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

BiopharmaBiotechnologyHealth CareTherapeutics
Series BApr 14, 2020
Amount Raised: $145,000,000
Anaeropharma Science

Tokyo, Tokyo, Japan

Anaeropharma is a biopharmaceutical company engaged in research and development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series UnknownJan 1, 2020
Spire Global

San Francisco, California, United States

Spire Global is a space to cloud data analytics company utilizing satellites to provide maritime, aviation, and weather tracking.

AnalyticsBig DataData IntegrationInformation ServicesInformation Technology
Series DSep 25, 2019
Amount Raised: $40,000,000
NapaJen

Burlingame, California, United States

NapaJen Pharma is a Pharmaceutical company designed to supply drugs in effective methods to end up active form in the organ.

BiotechnologyHealth CareMedicalPharmaceutical
Series CJan 9, 2019
Amount Raised: $12,400,000
MC10

Lexington, Massachusetts, United States

MC10 develops virtually invisible, conformal electronics that reshape rigid conventional electronics into thin flexible devices.

ElectronicsSemiconductorWearables
Series UnknownAug 20, 2018
Amount Raised: $10,028,000
Element

Oakland, California, United States

SaaS provider transforming IT/OT data into contextualized, graph-based models to support diverse analytical workloads and data governance.

AnalyticsBig DataData GovernanceInternet of ThingsPredictive AnalyticsSaaSSoftware
Series AJan 8, 2018
Amount Raised: $15,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator